Nexstim Plc (NXTMH):企業の財務・戦略的SWOT分析

◆英語タイトル:Nexstim Plc (NXTMH) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDME7231FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年1月
◆ページ数:50
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フィンランド
◆産業分野:Medical Devices
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD250 ⇒換算¥35,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥53,250見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Nexstim Plc (NXTMH) – Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Nexstim Plc (Nexstim), a medical technology company that develops, manufactures and commercializes non-invasive brain stimulation technologies and devices to treat patients suffering from depressive disorders and chronic pain. The company provides Navigated Brain Therapy (NBT) system for the treatment of major depression disorder (MDD) and chronic neuropathic pain and Navigated Brain Stimulation (NBS) system for pre-surgical diagnostics. It develops products based on its proprietary SmartFocus TMS technology. Nexstim offers its products primarily to leading hospitals and universities through direct sales and distributors in the US, Europe, and Asia. The company has operations in Finland, Germany and the US. Nexstim is headquartered in Helsinki, Finland.

Nexstim Plc Key Recent Developments

Nov 18,2020: Nexstim signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project
Aug 14,2020: Nexstim half-yearly report 1 January – 30 June 2020
Aug 13,2020: Nexstim updates its corporate strategy
Jun 16,2020: Nexstim : Mikko Karvinen appointed as permanent CEO and Joonas Juokslahti as permanent CFO
Apr 03,2020: Nexstim updates its future outlook for the full year 2020

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

【レポートの目次】

Table of Contents
List of Tables
List of Figures
Section 1 – About the Company
Nexstim Plc – Key Facts
Nexstim Plc – Key Employees
Nexstim Plc – Key Employee Biographies
Nexstim Plc – Major Products and Services
Nexstim Plc – History
Nexstim Plc – Company Statement
Nexstim Plc – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Nexstim Plc – Business Description
Business Segment: NBS Other sales
Performance
Business Segment: NBS Systems
Overview
Performance
Key Stats
Business Segment: NBT Other sales
Performance
Business Segment: NBT Systems
Overview
Performance
Geographical Segment: Finland
Performance
Geographical Segment: North America
Performance
Geographical Segment: Other
Performance
Geographical Segment: Rest of Europe
Performance
Nexstim Plc – Corporate Strategy
Nexstim Plc – SWOT Analysis
SWOT Analysis – Overview
Nexstim Plc – Strengths
Nexstim Plc – Weaknesses
Nexstim Plc – Opportunities
Nexstim Plc – Threats
Nexstim Plc – Key Competitors
Section 3 – Company Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Performance Chart
Financial Performance
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts
Section 4 – Company’s Lifesciences Financial Deals and Alliances
Nexstim Plc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nexstim Plc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nexstim Plc, Recent Deals Summary
Section 5 – Company’s Recent Developments
Nov 18, 2020: Nexstim signs a purchase agreement worth EUR 0.9 million to develop and deliver two prototype systems for a research project
Aug 14, 2020: Nexstim half-yearly report 1 January – 30 June 2020
Aug 13, 2020: Nexstim updates its corporate strategy
Jun 16, 2020: Nexstim : Mikko Karvinen appointed as permanent CEO and Joonas Juokslahti as permanent CFO
Apr 03, 2020: Nexstim updates its future outlook for the full year 2020
Feb 28, 2020: Nexstim financial statements release 2019
Feb 11, 2020: Change in Nexstim management team – Joonas Juokslahti appointed as interim CFO
Feb 11, 2020: Nexstim CEO changes – Mikko Karvinen appointed as interim CEO
Jan 16, 2020: Nexstim‘s Technology licencing discussions ended with a leading California Based Academic Institution
Section 6 – Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

List of Tables
Nexstim Plc, Key Facts
Nexstim Plc, Key Employees
Nexstim Plc, Key Employee Biographies
Nexstim Plc, Major Products and Services
Nexstim Plc, History
Nexstim Plc, Subsidiaries
Nexstim Plc, Key Competitors
Nexstim Plc, Ratios based on current share price
Nexstim Plc, Annual Ratios
Nexstim Plc, Annual Ratios (Cont...1)
Nexstim Plc, Interim Ratios
Nexstim Plc, Medical Equipment, Deals By Year, 2015 to YTD 2021
Nexstim Plc, Medical Equipment, Deals By Type, 2015 to YTD 2021
Nexstim Plc, Recent Deals Summary
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Nexstim Plc (NXTMH):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Goldin Properties Holdings Ltd:企業の戦略・SWOT・財務分析
    Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report Summary Goldin Properties Holdings Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Ceres Nanosciences Inc:製品パイプライン分析
    Summary Ceres Nanosciences Inc (Ceres Nanosciences) is a provider of sample preparation products and diagnostic tests. The company offers Nanotrap particles for research and development and Nanotrap lyme antigen test that are protein enrichment toolset that can be integrated seamlessly into any exis …
  • East-Central Iowa Rural Electric Cooperative:企業の発電所・SWOT分析2018
    East-Central Iowa Rural Electric Cooperative - Power Plants and SWOT Analysis, 2018 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, inf …
  • Abiogen Pharma SpA:製薬・医療:M&Aディール及び事業提携情報
    Summary Abiogen Pharma SpA (Abiogen), a subsidiary of MDM Holding SpA, is a specialist pharmaceutical company, which develops, manufactures, and markets medicines with focus on musculo-skeletal health, and rare diseases. The company offers products in the form of oral solids, injectables, semi solid …
  • Energy Development Corp (EDC):電力:M&Aディール及び事業提携情報
    Summary Energy Development Corp (EDC), formerly Philippine National Oil Company, is a diversified renewable energy company. The company explores, develops, operates and utilizes geothermal energy and other indigenous renewable energy projects in the Philippines. EDC by utilizing geothermal energy an …
  • SIG Combibloc Group Ltd.:企業の戦略・SWOT・財務情報
    SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report Summary SIG Combibloc Group Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service o …
  • EXINI Diagnostics AB-医療機器分野:企業M&A・提携分析
    Summary EXINI Diagnostics AB (EXINI), a subsidiary of Progenics Pharmaceuticals Inc, is a healthcare IT company that offers development of software solutions for the medical diagnostic market. The company’s software solutions include EXINIbone, EXINIheart, EXINIbrain and EXINIdat. Its EXINIbone is u …
  • Direct Flow Medical Inc-医療機器分野:企業M&A・提携分析
    Summary Direct Flow Medical Inc (Direct Flow) is a medical device company that develops novel transcatheter heart valve technologies. The company provides transcatheter aortic valve implantation device without contrast. It also provides direct flow medical system, a technology for controlled and rel …
  • Aevi Genomic Medicine Inc (GNMX)-製薬・医療分野:企業M&A・提携分析
    Summary Aevi Genomic Medicine Inc (Aevi), formerly Medgenics Inc is a research and development company that discovers and develops novel therapies for pediatric onset and life-altering diseases.The company’s pipeline products include AEVI-001 and AEVI-002. Its lead product AEVI-001, is a glutamaterg …
  • BW Offshore Ltd (BWO):石油・ガス:M&Aディール及び事業提携情報
    Summary BW Offshore Ltd (BW Offshore) is a floating production services provider to the oil and gas industry. The company specializes in the design, development, and operation of oil and gas Floating Production, Storage and Offloading (FPSO) and Floating, Storage and Offloading (FSO) vessels. It off …
  • Atopix Therapeutics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Atopix Therapeutics Ltd (Atopix) is a clinical stage biotechnology company that develops novel treatments for Th2-mediated eosinophilic asthma. The company’s product portfolio includes CRTH2 used in the treatment of atopic dermatitis. It also offers ATX2417 and OC459 used in treatment of ast …
  • Gruma, S.A.B. de C.V.:企業の戦略・SWOT・財務情報
    Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report Summary Gruma, S.A.B. de C.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Ryosan Company, Ltd:企業の戦略・SWOT・財務情報
    Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report Summary Ryosan Company, Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Carrabba’s Italian Grill, Inc.:企業の戦略・SWOT・財務情報
    Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report Summary Carrabba's Italian Grill, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Lidco Group Plc (LID):医療機器:M&Aディール及び事業提携情報
    Summary Lidco Group Plc (LiDCO) is a medical device company that supplies hemodynamic monitoring equipment. The company offers products such as LiDCOrapid, LiDCOunity, LiDCOplus, LiDCOview and LiDCOaccessories . Its LiDCOplus is a computer-based platform monitor, which is used in the intensive care …
  • Rockwell Collins Inc:企業のM&A・事業提携・投資動向
    Rockwell Collins Inc - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Rockwell Collins Inc Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A …
  • Greencore Group Plc:戦略・SWOT・企業財務分析
    Greencore Group Plc - Strategy, SWOT and Corporate Finance Report Summary Greencore Group Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Tellurian Inc (TELL):石油・ガス:M&Aディール及び事業提携情報
    Summary Tellurian Inc (Tellurian), formerly Magellan Petroleum Corp, is an oil and gas company that provides exploration, development, and production of crude oil and natural gas. The company develops liquefied natural gas production and export terminal on the west bank of the Calcasieu River, south …
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • CMS Energy Corporation:発電所・企業SWOT分析
    CMS Energy Corporation - Power Plants and SWOT Analysis, 2017 Update Summary The report contains a detailed description of the power generation company’s business operations, history, corporate strategy, and business structure. This report contains a detailed SWOT analysis, information on key employ …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆